Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter Norman. (2014) Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments. Expert Opinion on Orphan Drugs 2:11, pages 1137-1145.
Read now
Read now
Maria Klara Frey & Irene Lang. (2012)
Tadalafil for the treatment of pulmonary arterial hypertension. Expert Opinion on Pharmacotherapy 13:5, pages 747-755.
Read now
Read now
Articles from other publishers (27)
Tongyu Huo, Xinyi Zhao, Zengrui Cheng, Jialiang Wei, Minghui Zhu, Xiaodong Dou & Ning Jiao. (2023) Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Azadeh Issapour, Benjamin Frank, Sarah Crook, Michelle D. Hite, Michelle L. Dorn, Erika B. Rosenzweig, D. Dunbar Ivy & Usha S. Krishnan. (2022) Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real‐world experience. Pediatric Pulmonology 57:3, pages 724-733.
Crossref
Crossref
Adam Mieczkowski, Elżbieta Speina, Damian Trzybiński, Maria Winiewska-Szajewska, Patrycja Wińska, Ewelina M. Borsuk, Małgorzata Podsiadła-Białoskórska, Tomasz Przygodzki, Krzysztof Drabikowski, Lidia Stanczyk, Igor Zhukov, Cezary Watala & Krzysztof Woźniak. (2021) Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile. Molecules 26:4, pages 794.
Crossref
Crossref
Dunbar Ivy & Benjamin S. Frank. (2021) Update on pediatric pulmonary arterial hypertension. Current Opinion in Cardiology 36:1, pages 67-79.
Crossref
Crossref
Benjamin S. Frank & D. Dunbar Ivy. (2020) Pediatric Pulmonary Arterial Hypertension. Pediatric Clinics of North America 67:5, pages 903-921.
Crossref
Crossref
Catherine M. Avitabile, Erika E. Vorhies & David Dunbar Ivy. (2020) Drug Treatment of Pulmonary Hypertension in Children. Pediatric Drugs 22:2, pages 123-147.
Crossref
Crossref
Benjamin S. Frank & D. Dunbar Ivy. (2020) Pediatric Pulmonary Arterial Hypertension: Evaluation and Treatment. Current Treatment Options in Pediatrics 6:1, pages 12-28.
Crossref
Crossref
Erika B. Rosenzweig, Steven H. Abman, Ian Adatia, Maurice Beghetti, Damien Bonnet, Sheila Haworth, D. Dunbar Ivy & Rolf M.F. Berger. (2019) Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. European Respiratory Journal 53:1, pages 1801916.
Crossref
Crossref
Benjamin Frank & D. Ivy. (2018) Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children. Children 5:4, pages 44.
Crossref
Crossref
Dunbar Ivy. 2018. Heart Failure in the Child and Young Adult. Heart Failure in the Child and Young Adult
399
412
.
Dunbar Ivy. (2016) Pulmonary Hypertension in Children. Cardiology Clinics 34:3, pages 451-472.
Crossref
Crossref
Sivasubramanian Ramakrishnan. (2015) Current Concepts in Management of Pulmonary Hypertension: Fighting the Old Demon with Modern Weapons. The Indian Journal of Pediatrics 82:12, pages 1128-1134.
Crossref
Crossref
Steven H. Abman, Georg Hansmann, Stephen L. Archer, D. Dunbar Ivy, Ian Adatia, Wendy K. Chung, Brian D. Hanna, Erika B. Rosenzweig, J. Usha Raj, David Cornfield, Kurt R. Stenmark, Robin Steinhorn, Bernard Thébaud, Jeffrey R. Fineman, Titus Kuehne, Jeffrey A. Feinstein, Mark K. Friedberg, Michael Earing, Robyn J. Barst, Roberta L. Keller, John P. Kinsella, Mary Mullen, Robin Deterding, Thomas Kulik, George Mallory, Tilman Humpl & David L. Wessel. (2015) Pediatric Pulmonary Hypertension. Circulation 132:21, pages 2037-2099.
Crossref
Crossref
M. S. Rahnama’i, R. Hohnen, Ph. E. V. Van Kerrebroeck & G. A. van Koeveringe. (2014) Phosphodiesterase type 2 distribution in the guinea pig urinary bladder. World Journal of Urology 33:10, pages 1623-1633.
Crossref
Crossref
Michael R. Bristow & Robert A. Quaife. (2015) The Adrenergic System in Pulmonary Arterial Hypertension: Bench to Bedside (2013 Grover Conference Series). Pulmonary Circulation 5:3, pages 415-423.
Crossref
Crossref
Andreas Papapetropoulos, Adrian J Hobbs & Stavros Topouzis. (2015) Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS. British Journal of Pharmacology 172:6, pages 1397-1414.
Crossref
Crossref
Erika E. Vorhies & David Dunbar Ivy. (2013) Drug Treatment of Pulmonary Hypertension in Children. Pediatric Drugs 16:1, pages 43-65.
Crossref
Crossref
D. Dunbar Ivy, Steven H. Abman, Robyn J. Barst, Rolf M.F. Berger, Damien Bonnet, Thomas R. Fleming, Sheila G. Haworth, J. Usha Raj, Erika B. Rosenzweig, Ingram Schulze Neick, Robin H. Steinhorn & Maurice Beghetti. (2013) Pediatric Pulmonary Hypertension. Journal of the American College of Cardiology 62:25, pages D117-D126.
Crossref
Crossref
Masrat Rashid, Mohammad Fahim & Anita Kotwani. (2012) Efficacy of tadalafil in chronic hypobaric hypoxia–induced pulmonary hypertension: possible mechanisms. Fundamental & Clinical Pharmacology 27:3, pages 271-278.
Crossref
Crossref
Dioma U. Udeoji & Ernst R. Schwarz. (2012) Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Therapeutic Advances in Respiratory Disease 7:1, pages 39-49.
Crossref
Crossref
Shinichi Takatsuki, Michelle Calderbank & David Dunbar Ivy. (2012) Initial Experience With Tadalafil in Pediatric Pulmonary Arterial Hypertension. Pediatric Cardiology 33:5, pages 683-688.
Crossref
Crossref
Dunbar Ivy. (2012) Advances in pediatric pulmonary arterial hypertension. Current Opinion in Cardiology 27:2, pages 70-81.
Crossref
Crossref
Panagiota Nikolaou, Ioannis Papoutsis, Sotirios Athanaselis, Giorgos Alevisopoulos, Alaa Khraiwesh, Constantinos Pistos & Chara Spiliopoulou. (2011) Development and validation of a GC/MS method for the determination of tadalafil in whole blood. Journal of Pharmaceutical and Biomedical Analysis 56:3, pages 577-581.
Crossref
Crossref
E. Kolosionek, B.B. Graham, R.M. Tuder & G. Butrous. (2011) Pulmonary vascular disease associated with parasitic infection—the role of schistosomiasis. Clinical Microbiology and Infection 17:1, pages 15-24.
Crossref
Crossref
Javier Gaudó Navarro & Antonio Sueiro Bendito. (2011) Tadalafilo: nuevos aspectos de la inhibición de la fosfodiesterasa tipo 5 en el tratamiento de la hipertensión pulmonar. Archivos de Bronconeumología 47, pages 26-31.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:2, pages 111-120.
Crossref
Crossref
Dimitar Sajkov, Nikolai Petrovsky & Paolo Palange. (2010) Management of dyspnea in advanced pulmonary arterial hypertension. Current Opinion in Supportive & Palliative Care 4:2, pages 76-84.
Crossref
Crossref